Related Experiment Video
Updated: Sep 20, 2026
09:26
The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse
Published on: May 16, 2016
Intra-articular injections with high molecular weight sodium hyaluronate as a therapy for canine arthritis
L E Hellström1, C Carlsson, J F Boucher
1Läckeby Djursjukhus, Orntorp 4007, 380 31 Läckeby, Sweden.
The Veterinary Record
|August 2, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog.
Journal of veterinary pharmacology and therapeutics·2013
The pharmacokinetics of maropitant citrate dosed orally to dogs at 2 mg/kg and 8 mg/kg once daily for 14 days consecutive days.
Journal of veterinary pharmacology and therapeutics·2012
Pharmacokinetics of ceftiofur crystalline-free acid sterile suspension in the equine.
Journal of veterinary pharmacology and therapeutics·2011
The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs.
Journal of veterinary pharmacology and therapeutics·2010
Towards optimised information about clinical trials; identification and validation of key issues in collaboration with cancer patient advocates.
European journal of cancer care·2010
Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors.
Journal of veterinary pharmacology and therapeutics·2010
Survey of the health and welfare of imported dogs presenting to UK veterinary surgeons.
The Veterinary record·2026
Eculizumab in rapidly progressive glomerulonephritis: a case-series report.
Frontiers in immunology·2026
Flurbiprofen for Inflammatory Bowel Disease: A Review of Colon-Targeted Formulations.
Recent advances in drug delivery and formulation·2026
Heart-specific T cell responses: from antigens to disease mechanisms.
Nature reviews. Cardiology·2026
Perioperative immune-based treatment for cisplatin-eligible muscle-invasive bladder cancer: a meta-analysis of randomized controlled trials.
Critical reviews in oncology/hematology·2026